Program Description
***THIS PROGRAM HAS EXPIRED***
Alzheimer’s disease is a debilitating problem for both patients and families, and with increasing elderly populations in the United States it will continue to grow. Practitioners need to be armed with the latest diagnosis, screening, and management tools, as well as be aware of the importance of clinical research in this area. As an expert in the area, Dr. Cummings will discuss Alzheimer’s disease and ways to improve management in primary care.
Hosted by
Anthony Alessi, MD
Learning Objectives
- Outline the steps that are important in arriving at an accurate and clear diagnosis of dementia, and educate patients and their families on the process
- Identify patients who are candidates to participate in AD research and discuss with them the importance of participation
Target Audience
The target audience for this educational activity is physicians.
Faculty/Disclosures
Faculty:
Jeffrey L. Cummings, MD
Director, Mary S. Easton Center for Alzheimer’s Disease Research
University of California, Los Angeles
Dr. Cummings is a consultant for Abbott; Acadia; Accera; Adamas; Astellas; Avanir; Bristol-Myers Squibb; CoMentis; Eisai; Elan; EnVivo; Forest; GlaxoSmithKline; Janssen; Lilly; Lundbeck; Medivation; Merck; Merz; Myriad; Neuren; Novartis; Noven; Pfizer; Prana; reMYND; Schering-Plough; Sonexa; Takeda; Toyama; and Wyeth.
Dr. Cummings is on the speakers' Bureaus for Eisai; Forest; Janssen; Lundbeck; Merz; Novartis; and Pfizer
Clinical Editor:
Christopher J. Drury
Mr. Drury has nothing to disclose.
Accreditation
Pri-Med Institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Pri-Med Institute designates this educational activity for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Provider
Pri-Med is a brand within M|C Communications, LLC. Offered through the Pri-Med brand are both educational solutions for physicians and allied health professionals and non-CME product information sharing and exhibit opportunities for industry. Pri-Med's educational solutions are fully firewalled from the non-CME offerings and are developed compliantly and in accordance with accrediting organization requirements and standards, including the ACCME. Pri-Med's CME provides health care practitioners with access to evidence-based education through innovative learning formats designed to meet their individual needs. Pri-Med's offerings include 120+ live meetings and conventions across the U.S., in the UK, and Germany; 300+ online CME activities and web-based tools and resources on www.pri-med.com, one of the top ten CME websites available to physicians; and 60+ print publications read by 200,000+ clinicians.
Commercial Support
Pri-Med Institute gratefully acknowledges the educational grant provided by Eisai and Forest.
Disclosure of Unlabeled Use
This presentation may contain mention of unapproved or investigational therapeutic agents. Pri-Med Institute and this activity's commercial grantors do not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Instruction for Participation
To earn continuing education credit, simply listen to the podcast program. Learners must then complete a posttest and evaluation and receive a passing score of 70% or more on the posttest. Upon submission of the evaluation, learners will have the option of printing a certificate for their records.